Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORAL-21Generic

ORTHO-NOVUM 10-21

MESTRANOL; NORETHINDRONE

Standard Dose
0.06MG;10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ORTHO-NOVUM 10-21 is listed in Drugs@FDA under application 012728 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MESTRANOL; NORETHINDRONE Form and strength TABLET;ORAL-21 - 0.06MG;10MG Sponsor ORTHO MCNEIL PHARM Submission history Latest submission status date: 2000-01-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORTHO-NOVUM 10-21 is listed in Drugs@FDA under application 012728 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MESTRANOL; NORETHINDRONE Form and strength TABLET;ORAL-21 - 0.06MG;10MG Sponsor ORTHO MCNEIL PHARM Submission history Latest submission status date: 2000-01-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.